By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

LG Life Sciences, Ltd. 

LG Twin Tower, East Tower
20, Yoido-dong, Youngdungpo-gu
Seoul      Korea
Phone: 82-2-3773-1114 Fax: 82-2-3773-7012


SEARCH JOBS


Industry
Biotechnology

Segment
Life Sciences





Company News
BioPartners GmbH and LG Life Sciences, Ltd. Present Positive Phase 3, Twenty-Four Months Efficacy and Safety Data for Sustained Release Recombinant Human Growth Hormone (LB03002) Given to Children with Growth Hormone Deficiency 9/27/2011 8:03:23 AM
Novavax, Inc. (NVAX) Licenses Recombinant VLP Influenza Vaccine to LG Life Sciences, Ltd. for South Korea and Other Countries 3/1/2011 10:20:14 AM
Novavax, Inc. (NVAX) Licenses Recombinant VLP Influenza Vaccine to LG Life Sciences, Ltd. for South Korea and Other Countries 3/1/2011 8:34:47 AM
BioPartners GmbH And LG Life Sciences, Ltd. Present Positive Phase 3, Placebo-Controlled Six Month Efficacy and Safety Data for Sustained Release Recombinant Human Growth Hormone (LB03002) Given to Adults with Growth Hormone Deficiency 6/11/2009 12:01:16 PM
Gilead Sciences, Inc. (GILD) and LG Life Sciences, Ltd. Announce Global License Agreement to Advance Novel Drug Candidates for Treatment of Fibrotic Diseases 11/7/2007 11:32:44 AM
Oscient Pharmaceuticals Corporation (OSCI) Amends Factive Contract With LG Life Sciences, Ltd.; Licensing For Factive Drug Includes All Of European Union 1/5/2007 11:15:41 AM
Anadys Pharmaceuticals, Inc. (ANDS) And LG Life Sciences, Ltd. Release: Completion Of ANA380 Dosing In Phase II Clinical Trial Confirms Robust Activity Against Lamivudine-Resistant Hepatitis B Virus 4/27/2006 10:14:36 AM
Sinovac Biotech Ltd. (SNVBF), And LG Life Sciences, Ltd. Announce Distribution Agreement To Market Vaccines In The Peoples Republic Of China 3/13/2006 11:31:09 AM
Depomed, Inc. (DEPO) , Biovail Corporation (BVF) Update Status Of Glumetza NDA10/19/2005 5:13:16 PM
Oscient Pharmaceuticals Corporation (OSCI) And LG Life Sciences, Ltd. Amend FACTIVE License Agreement; Modifications Include Adjustments To Royalty Rate Structure10/19/2005 5:13:13 PM
12
//-->